JPH0157955B2 - - Google Patents

Info

Publication number
JPH0157955B2
JPH0157955B2 JP59043617A JP4361784A JPH0157955B2 JP H0157955 B2 JPH0157955 B2 JP H0157955B2 JP 59043617 A JP59043617 A JP 59043617A JP 4361784 A JP4361784 A JP 4361784A JP H0157955 B2 JPH0157955 B2 JP H0157955B2
Authority
JP
Japan
Prior art keywords
leu
ser
ala
val
ctc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59043617A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60185799A (ja
Inventor
Masaaki Yamada
Taiji Furuya
Mitsue Notake
Junichi Yamagishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Priority to JP59043617A priority Critical patent/JPS60185799A/ja
Priority to DE1999175063 priority patent/DE19975063I2/de
Priority to EP85102093A priority patent/EP0155549B1/fr
Priority to AT85102093T priority patent/ATE61817T1/de
Priority to DE8585102093T priority patent/DE3582183D1/de
Priority to AU39448/85A priority patent/AU584608B2/en
Priority to CA000475653A priority patent/CA1341240C/fr
Priority to PH31937A priority patent/PH22108A/en
Priority to SU853869300A priority patent/SU1614765A3/ru
Priority to HU85828A priority patent/HU202921B/hu
Priority to ES540939A priority patent/ES8802159A1/es
Priority to KR1019850001374A priority patent/KR920010225B1/ko
Priority to DK100985A priority patent/DK172013B1/da
Publication of JPS60185799A publication Critical patent/JPS60185799A/ja
Priority to ES550939A priority patent/ES8703490A1/es
Publication of JPH0157955B2 publication Critical patent/JPH0157955B2/ja
Priority to US08/084,445 priority patent/US5288852A/en
Priority to FR99C0037C priority patent/FR99C0037I2/fr
Priority to NL990034C priority patent/NL990034I2/nl
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP59043617A 1984-03-06 1984-03-06 ヒト癌壊死因子 Granted JPS60185799A (ja)

Priority Applications (17)

Application Number Priority Date Filing Date Title
JP59043617A JPS60185799A (ja) 1984-03-06 1984-03-06 ヒト癌壊死因子
DE1999175063 DE19975063I2 (de) 1984-03-06 1985-02-26 DNS den menschlichen Tumornekrosisfaktor kodierendund das menschliche Tumornekronisfaktor-Polypepti d.
EP85102093A EP0155549B1 (fr) 1984-03-06 1985-02-26 ADN codant pour le facteur humain de nécrose de tumeur et le polypeptide du facteur humain de nécrose de tumeur
AT85102093T ATE61817T1 (de) 1984-03-06 1985-02-26 Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
DE8585102093T DE3582183D1 (de) 1984-03-06 1985-02-26 Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
AU39448/85A AU584608B2 (en) 1984-03-06 1985-03-01 DNA encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
CA000475653A CA1341240C (fr) 1984-03-06 1985-03-04 Adn codant pour le facteur de necrose tumorale humain, ainsi qu'un polypeptide agissant comme facteur de necrose tumorale humain
PH31937A PH22108A (en) 1984-03-06 1985-03-04 Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
HU85828A HU202921B (en) 1984-03-06 1985-03-05 Process for producing coding dns for human tumor necrosis factor the corresponding polypeptide with utilizing them and pharmaceutical compositions containing this polypeptide as active component
SU853869300A SU1614765A3 (ru) 1984-03-06 1985-03-05 Способ получени рекомбинантной плазмидной ДНК pHTN 713, кодирующей фактор некроза опухоли человека
ES540939A ES8802159A1 (es) 1984-03-06 1985-03-05 Un procedimiento de producir un acido desoxirribonucleico (adn)que tiene o contiene una secuencia de base que codificaun polipeptido de factor de necrosis tumoral de humano
KR1019850001374A KR920010225B1 (ko) 1984-03-06 1985-03-05 인간암괴사인자 및 그를 코우드하는 dna의 제법
DK100985A DK172013B1 (da) 1984-03-06 1985-03-05 DNA, vektor indeholdende dette DNA, vært transformeret med vektoren,polypeptid indeholdt i DNA'et og salt deraf, aggregat indeholdende polypeptidet samt pharmaceutisk sammensætning indeholdende polypeptidet eller aggregatet.
ES550939A ES8703490A1 (es) 1984-03-06 1986-01-16 Un procedimiento para producir un polipeptido que tiene o contiene un polipeptido de factor de necrosis de tumor humano
US08/084,445 US5288852A (en) 1984-03-06 1993-07-01 Human tumor necrosis factor polypeptides
FR99C0037C FR99C0037I2 (fr) 1984-03-06 1999-10-12
NL990034C NL990034I2 (nl) 1984-03-06 1999-10-12 DNA dat codeert voor humane tumor necrosis faktor en humane tumor necrosis faktor polypeptide.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59043617A JPS60185799A (ja) 1984-03-06 1984-03-06 ヒト癌壊死因子

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP63220749A Division JPH01156999A (ja) 1988-09-03 1988-09-03 ヒト癌壊死因子

Publications (2)

Publication Number Publication Date
JPS60185799A JPS60185799A (ja) 1985-09-21
JPH0157955B2 true JPH0157955B2 (fr) 1989-12-08

Family

ID=12668798

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59043617A Granted JPS60185799A (ja) 1984-03-06 1984-03-06 ヒト癌壊死因子

Country Status (2)

Country Link
JP (1) JPS60185799A (fr)
SU (1) SU1614765A3 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
GR851626B (fr) * 1984-07-05 1985-11-26 Genentech Inc
JP2675294B2 (ja) * 1984-10-15 1997-11-12 カイロン コーポレイション ヒト腫瘍壊死因子
ATE73856T1 (de) * 1984-12-21 1992-04-15 Biogen Inc Reinigung, herstellung und verwendung von tumor- nekrosisfaktoren.
DE68926679T2 (de) * 1988-09-22 1996-10-17 Teijin Ltd Physiologisch aktives polypeptid, rekombinantes plasmid, rekombinante mikrobielle zellen, medizinisches präparat sowie verfahren zur gewinnung des gereinigten polypeptids
JPH0242986A (ja) * 1989-06-28 1990-02-13 Asahi Chem Ind Co Ltd 新規なヒト生理活性ポリペプチドをコードするｄｎａ
JPH07101993A (ja) * 1993-10-01 1995-04-18 Akira Kaji 新規抗腫瘍性ペプチド
WO2012069568A2 (fr) * 2010-11-25 2012-05-31 Imnate Sarl Peptides immunogènes destinés à la prévention et/ou au traitement de maladies infectieuses, de maladies auto-immunes, de réponses immunitaires aux allofacteurs, de maladies allergiques, de tumeurs, du rejet de greffe, et des réponses immunitaires dirigées contre des vecteurs viraux utilisés en thérapie génique ou en vaccination génique

Also Published As

Publication number Publication date
JPS60185799A (ja) 1985-09-21
SU1614765A3 (ru) 1990-12-15

Similar Documents

Publication Publication Date Title
EP0155549B1 (fr) ADN codant pour le facteur humain de nécrose de tumeur et le polypeptide du facteur humain de nécrose de tumeur
JP2557053B2 (ja) 腫瘍壊死因子の精製、製造および使用法
US5288852A (en) Human tumor necrosis factor polypeptides
JPS60252496A (ja) 新規なヒト生理活性ポリペプチド
EP0146026A2 (fr) ADN codant pour TNF de lapin, vecteur dans lequel cet ADN est inséré, hôte transformé par ce vecteur, polypeptide TNF de lapin et procédé pour sa préparation
US5247070A (en) N-terminal muteins of tumor necrosis factor
JPH107699A (ja) インターフェロン−γの産生を誘導するポリペプチド
JPH0157955B2 (fr)
US5519119A (en) Muteins of TNF pharmaceutical compositions and a method of making
JP2634132B2 (ja) 新規ペプチド
JPH0827189A (ja) インターフェロン−γの産生を誘導する蛋白質
JP2515975B2 (ja) 抗腫瘍作用を有するポリペプチド
JP2002523100A (ja) 新規なヒトリゾチーム遺伝子、それによりコードされたポリペプチド、およびそれらの作製方法
JPS6034915A (ja) ポリペプチド
JPH01156999A (ja) ヒト癌壊死因子
JP2584206B2 (ja) ヒト癌壊死因子
JP2675294B2 (ja) ヒト腫瘍壊死因子
JPS60232097A (ja) ヒト癌壊死因子ポリペプチドの製造法
JP2002523099A (ja) 新規なヒトリゾチーム遺伝子、それによりコードされたポリペプチド、およびそれらの作製方法
JP3897343B2 (ja) 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
JPH066066B2 (ja) 遺伝子組換体の産生する生理活性物質の熱処理法
WO2000012717A1 (fr) Nouveau gene de lysozyme humain, polypeptide codant pour celui-ci et leur procede de preparation
JP3542763B2 (ja) インターフェロン−γの産生を誘導する蛋白質
EP0477791A2 (fr) Polypeptide
JP2544255B2 (ja) ヒト インタ―ロイキン１活性を有するポリペプチドの製法

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term